Cause IQ organization profile

Multiple Myeloma Research Foundation (MMRF)

Program areas | Form 990s | Financials | Vendors | Personnel | Peers

MMRF is a medical practice research organization based in Norwalk, CT that was founded in 1998. As of 2019 they had $44 million in revenue and $69 million in assets.

The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.

EIN:
06-1504413
City:
State:
Metro:
Website:
Phone:
203.229.0464
Facebook:
Twitter:
Founded:
1998
Type:
501(c)(3)
NTEE:
Revenue:
$44,172,260
Assets:
$69,711,900
Employees:
51
Fiscal year end:
December
Revenue trends:
Asset trends:

Program areas at MMRF

The Multiple Myeloma Research Foundation (mmrf) supports investigators and scientific projects through a number of Research grants. The goal of this initiative is to accelerate The development of therapeutic approaches for Myeloma through our unique end-to-end model that supports efforts in basic science, or translation research.in 2017 The mmrf awarded multi-year grants for three new programs. In data analytics & analysis, mmrf awarded $1 million to investigators for our answer fund, which will leverage The landmark mmrf commpass study to identify The next generation of therapeutic targets and/or pathways or biomarkers for high-risk Multiple Myeloma (mm) patients. In immunotherapy, $7 million was awarded to create The immune networks of excellence. These multicenter, and multinational, Research partnerships of world-class scientists and clinicians will accelerate Research into The role of The patient immune system in Myeloma biology and disease progression, and characterize The changes in The immune system associated with The patient's ...

The mmrf longitudinal study (commpass) commenced in 2011 and has been extended through 2023. Mmrf is The sponsor of a personalized medicine initiative in which 1,153 newly diagnosed patients have been enrolled to date through 108 sites (i.e., hospitals, academic medical centers and other community health centers) across north america and europe. This is an observational study, rather than an interventional one with experimental drugs being tested. Biospecimens (like blood and bone marrow samples) are collected from The patients periodically over The course of their treatment along with correlating clinical data. The standard of care (i.e., drugs and treatment) for each patient is determined by such patient's personal physician. The tissue samples collected are placed in a biobank. An unrelated, third party, not-for-profit biomedical Research institute then performs laboratory tests on a portion of each of The samples resulting in genomic data about each patient. Our goal is to build ...

The Multiple Myeloma Research consortium, llc. (mmrc) is a subsidiary of The Multiple Myeloma Research Foundation. The mmrc is The first Research model that brings together 25 leading academic centers with industry partners to conduct highly collaborative phase 1 and phase 2 clinical trials of novel compounds and combination treatments for Multiple Myeloma. All centers are driven by highly defined metrics that mandate accountability and strongly promote team science. There are currently several treatments in The pipeline, including those that target genomic markers, immunotherapies, and novel agents and mechanisms. In 2018, mmrf through mmrc opened 4 clinical trials and enrolled over 200 patients across 25 trials. From its inception, mmrc has enrolled over 2,000 patients across more than 80 clinical trials.

Form 990s for MMRF

Fiscal year endingDate received by IRSFormPDF link
2018-12Nov 22, 2019990View PDF
2017-12Feb 21, 2019990View PDF
2016-12Jan 18, 2018990View PDF
2015-12Apr 19, 2017990View PDF
2014-12Sep 21, 2015990View PDF
...and eight more Form 990 PDFs

Financials for MMRF

Field2018
Total grants, contributions, etc.$41,335,585
Program services$3,610,454
Investment income and dividends$1,090,003
Tax-exempt bond proceeds$0
Royalty revenue$277,528
Net rental income$0
Net gain from sale of non-inventory assets$35,386
Net income from fundraising events$-2,176,696
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$44,172,260

Vendors for MMRF

VendorServicesAmount paidDate
WordPressContent management system software2020-06-16
███ ████████ ██████ ███Tax accounting2019-10-22
█████ ███ ███5K Event Management$1,458,8942018-12-01
█████Tissue and Gene Analysis$1,948,9772018-12-01
████████ ███Continuing Medical Education$947,7012018-12-01
█████████ ████████Contract Research$1,546,2602018-12-01
█████ ███Strategic Planning$2,123,5002018-12-01
██████████Marketing software2018-04-27
...and three more vendors

Personnel at MMRF

NameTitleCompensationMost recent data
Carol A. Ammon FoundationPresident and Chief Executive Officer-Aug. 21, 2020
Marie E. PinizzottoPresident and Chief Executive Officer , Carol A Ammon Foundation / Board Member$0Aug. 21, 2020
████ ██████President and Chief Executive Officer$604,080Aug. 21, 2020
██████ █████Chief Executive Officer / Board Member$0Aug. 21, 2020
███████ █████████Chairman and Chief Executive Officer / Board Member$0Aug. 21, 2020
███████ ████████Chief Operating Officer-Aug. 21, 2020
███ █████Chief Financial Officer / Chief Finance Officer-Aug. 21, 2020
██████ █████Treasurer and Chief Financial Officer$303,326Nov. 22, 2019
████ █████ █████Chief Marketing and Development Officer / Chief Marketing and Dev Officer$229,709Aug. 21, 2020
██████ ███████Chief Data Officer-Aug. 21, 2020
...and 17 more key personnel

Peer medical discipline research centers

 NameTypeRevenueLocation
1Cystic Fibrosis Foundation Therapeutics (CFF)501(c)(3)$125 millionBethesda, MD
2Aids Research Foundation or amfAR501(c)(3)$32 millionNew York, NY
3The California Institute for Biomedical Research (Calibr)501(c)(3)$98 millionLa Jolla, CA
4Magee-Womens Research Institute and Foundation (MWRI)501(c)(3)$61 millionPittsburgh, PA
5American Technion Society501(c)(3)$80 millionNew York, NY
6HudsonAlpha Institute for Biotechnology501(c)(3)$80 millionHuntsville, AL
7New York Genome Center (NYGC)501(c)(3)$128 millionNew York, NY
8Tri-Institutional Therapeutics Discovery Institute (TDI)501(c)(3)$20 millionNew York, NY
9Melanoma Research Alliance (MRA)501(c)(3)$24 millionWashington, DC
10American Thrombosis and Hemostasis Network (ATHN)501(c)(3)$11 millionRochester, NY
11TB Alliance (TB Alliance)501(c)(3)$63 millionNew York, NY
12Quantum Leap Healthcare Collaborative501(c)(3)$12 millionSan Francisco, CA
13Gary and Mary West Health Institute501(c)(3)$25 millionLa Jolla, CA
14Health Effects Institute (HEI)501(c)(3)$12 millionBoston, MA
15Swedish Medical Center Foundation501(c)(3)$39 millionRenton, WA
16American College of Gastroenterology (ACG)501(c)(3)$34 millionBethesda, MD
17W.W. Caruth Jr. Foundation501(c)(3)$17 millionDallas, TX
18National Organization for Rare Disorders (NORD)501(c)(3)$47 millionQuincy, MA
19Cure Pancreatic Cancer Lustgarten Foundation501(c)(3)$44 millionWoodbury, NY
20Damon Runyon Cancer Research Foundation501(c)(3)$21 millionNew York, NY
21Children's Health Care Foundation501(c)(3)$25 millionMinneapolis, MN
22Brain and Behavior Research Foundation501(c)(3)$19 millionNew York, NY
23Foundation Fighting Blindness (FFB)501(c)(3)$53 millionColumbia, MD
24Cancer Research Institute (CRI)501(c)(3)$25 millionNew York, NY
25JRF Ortho (JRF)501(c)(3)$42 millionCentennial, CO